PPI Deprescribing Patient Decision Aid

Decision aids are tools that facilitate shared decision-making. They provide patients with information about the benefits and harms of different options and allow patients to clarify what is important to them about these options.

As part of his post-graduate work with the Bruyère Research Institute, Dr. Wade Thompson developed a consult patient decision aid based on the proton pump inhibitor deprescribing guideline. Developed by the Bruyère Deprescribing Guidelines led team of health care and research experts, the evidence-based guidelines are products of quality research and real-world application.

For more information on deprescribing, please refer to our Deprescribing Information Pamphlets section of our website.

Publications

  • Thompson W, Farrell B, Welch V, Tugwell P, Way C, Richardson L, Bjerre L. Continuation or deprescribing of proton pump inhibitors: a consult patient decision aid. Canadian Pharmacists Journal December 2018 (available online ahead of publication: https://doi.org/10/1177/1715163518816719.
  • Thompson W, Farrell B, Welch V, Tugwell P, Bjerre LM. Should I continue taking my acid reflux medication? Design of a pilot before/after study evaluating a patient decision aid. Canadian Pharmacists Journal 2017;150(1):19-23. https://doi.org/10.1177/1715163516679425
Get Involved
Get Involved
Learn more
Need more info?
Need more info?
Contact us

“To actually flesh out protocols on how to deprescribe – that’s a huge leap forward. I think it’s going to be very useful.”

Pharmacist